GeneNews' Q3 Revenues Dip on Lower Licensing Revenues

The firm is preparing to launch its ColonSentry genetic test for colorectal cancer in the US and Asia.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories